1. Home
  2. CVKD vs EMKR Comparison

CVKD vs EMKR Comparison

Compare CVKD & EMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • EMKR
  • Stock Information
  • Founded
  • CVKD 2022
  • EMKR 1984
  • Country
  • CVKD United States
  • EMKR United States
  • Employees
  • CVKD N/A
  • EMKR N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • EMKR Semiconductors
  • Sector
  • CVKD Health Care
  • EMKR Technology
  • Exchange
  • CVKD Nasdaq
  • EMKR Nasdaq
  • Market Cap
  • CVKD 8.2M
  • EMKR 9.8M
  • IPO Year
  • CVKD 2023
  • EMKR 1997
  • Fundamental
  • Price
  • CVKD $0.43
  • EMKR $1.16
  • Analyst Decision
  • CVKD Strong Buy
  • EMKR Buy
  • Analyst Count
  • CVKD 2
  • EMKR 2
  • Target Price
  • CVKD $3.50
  • EMKR $15.00
  • AVG Volume (30 Days)
  • CVKD 71.6K
  • EMKR 903.2K
  • Earning Date
  • CVKD 08-12-2024
  • EMKR 08-06-2024
  • Dividend Yield
  • CVKD N/A
  • EMKR N/A
  • EPS Growth
  • CVKD N/A
  • EMKR N/A
  • EPS
  • CVKD N/A
  • EMKR N/A
  • Revenue
  • CVKD N/A
  • EMKR $89,700,000.00
  • Revenue This Year
  • CVKD N/A
  • EMKR N/A
  • Revenue Next Year
  • CVKD N/A
  • EMKR $2.05
  • P/E Ratio
  • CVKD N/A
  • EMKR N/A
  • Revenue Growth
  • CVKD N/A
  • EMKR 511.83
  • 52 Week Low
  • CVKD $0.36
  • EMKR $0.78
  • 52 Week High
  • CVKD $2.17
  • EMKR $8.50
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 40.00
  • EMKR 45.14
  • Support Level
  • CVKD $0.43
  • EMKR $1.22
  • Resistance Level
  • CVKD $0.49
  • EMKR $1.51
  • Average True Range (ATR)
  • CVKD 0.02
  • EMKR 0.15
  • MACD
  • CVKD -0.00
  • EMKR 0.00
  • Stochastic Oscillator
  • CVKD 0.17
  • EMKR 12.50

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About EMKR EMCORE Corporation

EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.

Share on Social Networks: